Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Blister? 1,943 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,943 reports of Blister have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 5.0% of all adverse event reports for CABOZANTINIB S-MALATE.

1,943
Reports of Blister with CABOZANTINIB S-MALATE
5.0%
of all CABOZANTINIB S-MALATE reports
27
Deaths
150
Hospitalizations

How Dangerous Is Blister From CABOZANTINIB S-MALATE?

Of the 1,943 reports, 27 (1.4%) resulted in death, 150 (7.7%) required hospitalization.

Is Blister Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 1,943 reports have been filed with the FAERS database.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Blister?

ADALIMUMAB (4,819) METHOTREXATE (4,819) TOCILIZUMAB (4,485) ABATACEPT (4,344) LEFLUNOMIDE (4,338) ETANERCEPT (4,305) CERTOLIZUMAB PEGOL (4,181) ACETAMINOPHEN (4,043) GOLIMUMAB (3,975) PREDNISONE (3,876)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Blister Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Blister Reports All Drugs Causing Blister CABOZANTINIB S-MALATE Demographics